ÜBER DIESE EPISODE
In this episode of Humanitarian Horizons – Christina DiArcangelo Unveiled, Christina breaks down the growing concerns around compounded GLP-1 medications and what patients need to know to protect their health.
GLP-1 drugs like semaglutide and tirzepatide have become widely used for weight loss and metabolic health—but not all versions are the same. Christina explains the critical differences between FDA-approved GLP-1 medications and compounded alternatives, including concerns around safety, regulation, and patient awareness.
This episode highlights:
- The difference between FDA-approved and compounded GLP-1 medications
- Why clinical testing and manufacturing standards matter
- The importance of obtaining prescriptions through licensed healthcare providers
- The role of regulatory oversight in protecting patients
If you’re considering GLP-1 therapy, this is essential information to help you make informed decisions.
GLP-1, semaglutide, tirzepatide, compounded semaglutide, GLP-1 safety, FDA approved drugs, weight loss medication, diabetes medication, compounded pharmacy, patient safety, pharmaceutical regulation, clinical research, healthcare awareness, Christina DiArcangelo, humanitarian horizons, GLP-1 risks, medication safety
#GLP1 #Semaglutide #Tirzepatide #PatientSafety #HealthcareAwareness #FDA #WeightLoss #DiabetesCare #HumanitarianHorizons #ChristinaDiArcangelo
